"Community-based, eHealth Supported Management of Cardiovascular Risk Factors by Lay Village Health Workers (ComBaCaL aHT TwiC 1 & ComBaCaL aHT TwiC 2)"

NAActive, not recruitingINTERVENTIONAL
Enrollment

1,352

Participants

Timeline

Start Date

September 9, 2023

Primary Completion Date

June 1, 2025

Study Completion Date

June 1, 2025

Conditions
Arterial Hypertension
Interventions
DRUG

First-line antihypertensive single-pill combination (SPC)

In intervention villages, participants diagnosed with aHT are offered pharmacological treatment (eHealth supported prescription of first-line antihypertensive single-pill combination (SPC)) and treatment monitoring in the villages by CC-VHWs guided by the ComBaCaL app.

OTHER

Standardized counselling and referral to the closest health facility

In control villages, participants diagnosed with aHT receive a standardized counselling by the CC-VHW and are referred to the closest health facility for initiation or continuation of antihypertensive treatment.

Trial Locations (2)

4051

University Hospital Basel, Division of Clinical Epidemiology, Basel

Unknown

SolidarMed Lesotho, Maseru

All Listed Sponsors
collaborator

Swiss Agency for Development and Cooperation (SDC)

UNKNOWN

collaborator

World Diabetes Foundation (WDF)

UNKNOWN

lead

University Hospital, Basel, Switzerland

OTHER

NCT05684055 - "Community-based, eHealth Supported Management of Cardiovascular Risk Factors by Lay Village Health Workers (ComBaCaL aHT TwiC 1 & ComBaCaL aHT TwiC 2)" | Biotech Hunter | Biotech Hunter